BD
Becton, Dickinson and Company
BDX · NYSE
$179.18 -3.01% (-$5.56)
1M +2.84%
Market Cap $50.9B
P/E Ratio 54.10x
Div. Yield 2.03%
ROE 3.79%
Bulios Fair Price
$212.22
18.4% upside
Current Price
$179.18
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BDX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
47 /100
Fair P/E 54.10x
EV/EBITDA 17.20x
P/S 2.44x
Growth
47 /100
Stable EPS growth 0.28%
Rev. growth 4.99%
FCF growth 17.17%
Profitability
61 /100
Moderate Gross margin 46.12%
Net margin 4.52%
Op. margin 9.83%
Quality
20 /100
Poor ROIC 3.72%
ROE 3.79%
ROA 1.85%
Debt
43 /100
Moderate Debt/Equity 0.69x
Current ratio 0.87x
Int. coverage 3.93x
Stability
77 /100
Stable Beta 0.26x
Rev. volatility 2.88%
EPS volatility 17.34%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BDX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas E. Polen Jr.
Employees
72,000
Headquarters
Franklin Lakes
Upcoming events
09 SEP
Ex-Dividend
Ex-dividend date
30 SEP
Dividend Payment
Payment date
05 NOV
Earnings
Upcoming earnings report